共 50 条
- [41] Tixagevimab-cilgavimab for treatment of patients hospitalised with COVID-19: a randomised, double-blind, phase atrial LANCET RESPIRATORY MEDICINE, 2022, 10 (10): : 972 - 984
- [46] The Prevention of COVID-19 in High-Risk Patients Using Tixagevimab-Cilgavimab (Evusheld): Real-World Experience at a Large Academic Center AMERICAN JOURNAL OF MEDICINE, 2023, 136 (01): : 96 - 99